Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Take a look at the Chart (and the recent days lows). Do you notice the PPS has touch the same area several times and held (around $.0660 to $.0770). Holding up nicely!!!
http://www.stockta.com/cgi-bin/analysis.pl?symb=AMBS&cobrand=&mode=stock
As we move closer to the end of Q3; we could start to see some modest buying/accumulation ahead of a busy news week (potentially...no guarantees).
Also, Fridays have been good days for our PPS. The storm clouds will clear folks; just do your own DD (and sit back and wait).
Lastly, I have really good faith in our Mgt. team (still think Q3 is a huge turning point for this company). Only 7 business days left).
GLTA!!!
Does anybody find it ironic that there are large sell orders sitting on the ASK; but the person/investor is not selling them at $.001 lower (sort of like someone is putting a lid on retail buying).
MM's are suppressing the PPS; awaiting next news developments (emotional based investing will cost you a lot of money). Follow the CEO and watch the fundamentals..all very strong right now).
I think its a fair and reasonable question. I have been in the stock about 8-9 months now. Initially, when the PPS went up their was some trade groups who took a rather large position while the company was starting to make their intentions public regarding its business plan and potential for commercial success (within their portfolio). Unfortunately, they made their trading profit and quickly left...this stock was being pumped up beyond belief.
However, the cash situation has been rather bleak up to relationship established with Dominion capital. There was too much risk and uncertainty as to LymPro's future success, did MANF work and how the bills were to get paid.
In the last 6 months, we have make substantial progress with obtaining funding (from Dominion), adding new strategic advisors, updating the investment community on the continued progress with LymPro, announced Orphan data for MANF, and many science abstracts have been posted and published reinforcing the likelihood that MANF has enormous potential.
In summary, this company has incredible potential on both the Drug development and Diagnostic side...and as the cash situation and balance sheet have been cleaned up...the PPS is starting to rise one again. GLTA!!!
Interesting Chart pattern:
http://www.stockta.com/cgi-bin/analysis.pl?symb=AMBS&cobrand=&mode=stock
Looks like its primed for a breakout (but could base here at $.07). Look at the tight price action; it seems to be coiling for a big breakout.
You should post as you choose; and I read all messages here (one way or another). Honestly, I don't think anybody really cares how many shares you own....those who tell just want to stroke their own egos.
I am glad you have come to your senses and realize the true upside here...so don't think I am against you (just keep things real here...some who rant about a $15 stock next year should have their head examined).
I know his history here...he has played both sides of the fence. I believe he has a least 3 or 4 aliases on Yahoo as well.
Honestly, I think this MB has come a long way...got rid of the problem child's (quite a while ago). These far fetched and ridiculous projections are just utter nonsense (thought if a few individuals brought made light of it..things could settle down just a bit).
I don't need someone to educate me on what a Drug partnership is exactly. My concern: is that you are posting the same stuff (over and over) ...and that you have multiple aliases on Yahoo.
Actually, it would help your credibility to stop that relentless behavior...as I believe it will deter new investors from investing here.
Lastly, I am on your side (and know you mean well)....just tone it down a bit.
Your insight and feedback is appreciated. However, you have no idea at what stage a Pharma. will partner for any of the Orphan indications (it still could be 1 or 2 years away). Typically, a Pharma. will partner once an IND is filed or a drug is in a Phase 1 or 2.
Lets not get ahead of ourselves with pumping or making crazy predictions.
I will look forward to the day the PPS doesn't crash post a conference. I know Gerald just is an extremely transparent CEO (and that is very good).
Most importantly, I would like to see the presentations shift from how big the market sizes are ..(for their MANF indications and products) to what exactly is the MANF Orphan strategy. Moreover, what are the next steps for these Orphan indications?
Do we expect INDs to follow next year (years away) and what is the likelihood that Pharma's will partner sooner than later? We need real updates/announcements on the path towards commercialization (knowing an Orphan strategy will accelerate the timelines).
The Business plan highlights the goals/milestones ....I don't think its rocket science to predict news is coming on LymPro (knowing its due by the end of Sept. anyway).
Bull Flag pennant formation link:
http://stockcharts.com/school/doku.php?id=chart_school:chart_analysis:chart_patterns:flag_pennant_continu
Here is my advice:
"Follow the CEO"....he is been extremely forthcoming, transparent and very accurate (with meeting expectations). I realize he is not perfect, however, it just takes patience from here....which many don't seem to have whatsoever.
They just did a Debt offering last Friday (and can be up to $5mm) ...in addition to the recent Dominion Capital raise of up to $3mm+.
Please state the facts...and stop leaving out critical factual info.
MM's keeping a lid on this...awaiting good news (keeping the retail holders in check). Don't over analyze the situation (chart looks strong and Gerald has told everyone what's coming in Q3).
Eventually, there will be unexpected news and will catch many off guard (and I think its possible every trading day...and think getting in or adding at these levels is a true gift).
I would strongly recommend not to disclose your respective positions. Just my humble opinion....I don't think its smart to disclose your personal position to anybody posting on these boards.
I think the financing deal announced Friday is really significant. Management will have better leverage and negotiating power with more cash on the books. It can only help with companies like Becton Dickinson (with LymPro) and any other MANF Orphan deals with a Pharma.
As Jason Napodono has stated in his Analyst report; once a meaningful or significant capital raise happens; a paradigm shift may occur and an re evaluation of the shares leading to a much higher price.
Fridays capital raise link:
http://ir.stockpr.com/amarantus/all-sec-filings/content/0001144204-13-050679/formD.html
Thank you for the LymPro revenue update. I still think their is confusion with timing and potential of revenues. If FDA approval is not needed to push ahead and commercialize...why are so many Revenues occurring in 2016 (why not earlier)?
It appears that CLIA approval is sufficient (in 2014)...it could be a big difference in interpretation whether the PPS moves higher S/T (versus going up in a grinding fashion).
Can someone please post the old LymPro whitepaper that had the Financial projections (it no longer exists in the latest version). It will be interesting to see when Revenues can actually start for our PPS.
Thanks.
Can someone please post the old LymPro whitepaper that had the Financial projections (it no longer exists in the latest version). Thanks.
Genzyme article. Let me try posting this link again:
http://strategyatheinz.blogspot.com/2013/04/genzyme-company-exclusively-for-orphan.html
Genzyme is consider one of the kings of establishing an Orphan strategy (for their drug platform). In 2010, it sold for 20 billion (has 3.8 billion in sales today). Good read!!!
http://strategyatheinz.blogspot.com/2013/04/genzyme-company-exclusively-for-orphan.htmlhttp://strategyatheinz.blogspot.com/2013/04/genzyme-company-exclusively-for-orphan.html
Thank you for that informative reply (I was not aware of that reality). Great news!!!
Great post!!! I am wondering the same thing...will doctors be willing to use LymPro on their patients (if its only CLIA certified). How does the projected FDA approval directly affect sales both S/T and L/T?
In reality, its a Diagnostic tool (not a drug); so I don't see why it couldn't aide as a tool right away. But I am the internal optimist who believes Revenues will ramp up quickly (as AMBS will use a partner and distributor and not an internal sales force).
At least 460mm+ (but the latest Dominion financing deal will increase that some more....I believe todays Debt offering wont affect it).
Nice post Zoom! Lets hope this venture turns into something very big for our stock price. It sounds very promising; there is a contingency of people claiming this indication could have enormous potential for MANF (mostly several posters over on another board who seem to be connected within Scientific community).
Looks like a Debt offering; they are really looking to raise $$ quickly. I am hopeful with the huge portfolio; its time to start advancing key assets forward.
I would have to agree; I am perplexed that many find it rewarding to trade fractional penny profits. Bottom line: need BIG news ...it will help fix the problem.
Chart is looking great!!!! Cup and Handle formation is real!!!!
I agree and concur with your assessment. MM's in control until its time.
Its very simple:
Follow the CEO: He is extremely transparent and has indicated many good things to come. The day to day volatility and MB activity is meaningless as to where the PPS will go next.
Do you own DD and sit back and be patient. GLTA!!!
I believe its MM's who are trying to force weak hands before the upcoming breakout. A solid Cup and Handle formation is showing on the chart....a possible breakout is imminent or could happen in next few days (or week or so).
I posted the Cup and Handle chart formation yesterday evening. I think its real!!!
We might be heading down to re test 200 day moving avg. one more time (slightly below $.06)..time will tell.
MM's are just playing with it until big news hit (moved it down to wash out weak holders) before next big set up to higher highs.
I believe that an Orphan Diabetes indication has a good shot. But how can anybody really know what Novartis intentions are unless you are in Upper mgt. there(so I would be very skeptical as to this big partnership or huge alliance with them).
Lets keep things in perspective here...don't need the PPS to gap up and fall back hard...nice steady buying and movement upward.
I am hopeful that this formation will stick.
Good video to watch to explain it further.
See attached link: you will learn everything you need to know.
http://stockcharts.com/school/doku.php?id=chart_school:chart_analysis:chart_patterns:cup_with_handle_cont
We know that multiple news catalysts are looming (which have been outlined on this board over and over ...and is public information is reflected in Geralds presentations and timelines).
To me...the Chart has built a long cup over several months...the $.03 area was the bottom of the cup (which is primarily a basing formation). We touched $.09 the other day as a intraday high (which was the right side of the cup (and a former high on the chart a while back (now the cup is finished).
In progress, its forming the handle (the recent low at $.05 was the bottom of the handle. Its now in the last phase of finishing the right side of the handle ...which starts at $.05 and will progress and head up to the $.09 area (can happen in a day or few days).
You will see a massive breakout on high volume above $.09....and then a move up to well in the teens (or higher). Again...just a speculative theory..lets see who is right.
You are missing the point; its forming the right side of the Handle ...which means very positive news is imminent and will break it out above $.09. Just my two cents!